Tract Closure in PCNL
Recruiting
N/A
Interventional Study
Nephrolithiasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 92 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a prospective, randomized controlled trial evaluating the effect of a hemostatic agent on tract-related bleeding during percutaneous nephrolithotomy (PCNL). Patients undergoing standardized PCNL will be randomized to receive either application of a hemostatic agent or no agent during tract closure, following uniform balloon occlusion, complete aspiration, and irrigation-free endoscopic ass…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria:
* At least one stone ≥ 1.2cm
* Scheduled to undergo planned PCNL
* Age ≥ 18 years
Exclusion criteria:
* Unable to provide informed consent
* Pre-existing nephrostomy tube
* Multi access cases
* Stone in calyceal diverticulum/hydrocalyx
* Preoperatively planned overnight admiss…
Contacts